[Cardiac hypertrophy and calcium signaling].
Masayuki Asakawa, Issei Komuro
Abstract
Masayuki Asakawa, Issei Komuro
Abstract
Numerous studies have implicated intracellular Ca(2+) as a signal for cardiac hypertrophy. It has recently been reported that the calcium-dependent phosphatase calcineurin plays a critical role in the development of cardiac hypertrophy. It is also reported that cyclosporin A and FK506, calcineurin inhibitors, inhibit the development of cardiac hypertrophy. Inhibiting the calcineurin activity may be of potential benefit for prevention of cardiac hypertrophy and heart failure.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Numerous studies have implicated intracellular Ca(2+) as a signal for cardiac hypertrophy. It has recently been reported that the calcium-dependent phosphatase calcineurin plays a critical role in the development of cardiac hypertrophy. It is also reported that cyclosporin A and FK506, calcineurin inhibitors, inhibit the development of cardiac hypertrophy. Inhibiting the calcineurin activity may be of potential benefit for prevention of cardiac hypertrophy and heart failure.
Key concepts: Calcineurin, Cardiac hypertrophy, Muscle hypertrophy, Heart failure, Calcium, Medicine, Calcium in biology, Internal medicine